RAEGEN BOUDREAUX: Open Payments
NPI 1952883605 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 8 payments from 5 companies in 2025. Trend: 2023 $860 · 2024 $158 · 2025 $155
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $53 |
| AtriCure, Inc. | 2 | $50 |
| Novo Nordisk Inc | 1 | $20 |
| Kerecis Limited | 1 | $19 |
| Surmodics, Inc. | 1 | $14 |
Products named: ENROUTE Transcarotid Neuroprotection System, SYNERGY ABLATION SYSTEM, Rybelsus, Kerecis SurgiClose, Ranger, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, Sublime 014 Rx PTA Balloon Dilatation Catheter.
Industry payments across LA — which companies pay providers there.
